These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20676904)

  • 1. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
    Marsh SA; Dell'Italia LJ; Chatham JC
    Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
    Fülöp N; Marchase RB; Chatham JC
    Cardiovasc Res; 2007 Jan; 73(2):288-97. PubMed ID: 16970929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis.
    Rajamani U; Essop MF
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C139-47. PubMed ID: 20410435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
    Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
    Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
    Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
    J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.
    Marsh SA; Powell PC; Dell'italia LJ; Chatham JC
    Life Sci; 2013 Mar; 92(11):648-56. PubMed ID: 22728715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
    Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
    PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine.
    Nagy T; Champattanachai V; Marchase RB; Chatham JC
    Am J Physiol Cell Physiol; 2006 Jan; 290(1):C57-65. PubMed ID: 16107505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart.
    Cox EJ; Marsh SA
    Cardiovasc Diabetol; 2013 Jul; 12():101. PubMed ID: 23835259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased O-GlcNAcylation induces myocardial hypertrophy.
    Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
    In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity.
    Chatterjee A; Eshwaran R; Poschet G; Lomada S; Halawa M; Wilhelm K; Schmidt M; Hammes HP; Wieland T; Feng Y
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal regulation of protein O-GlcNAc levels during pressure-overload cardiac hypertrophy.
    Zhu WZ; Ledee D; Olson AK
    Physiol Rep; 2021 Aug; 9(15):e14965. PubMed ID: 34337900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights: A role for O-GlcNAcylation in diabetic complications.
    Peterson SB; Hart GW
    Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hexosamine biosynthesis pathway and O-GlcNAcylation maintain insulin-stimulated PI3K-PKB phosphorylation and tumour cell growth after short-term glucose deprivation.
    Jones DR; Keune WJ; Anderson KE; Stephens LR; Hawkins PT; Divecha N
    FEBS J; 2014 Aug; 281(16):3591-608. PubMed ID: 24938479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
    Champattanachai V; Marchase RB; Chatham JC
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.
    Liu J; Pang Y; Chang T; Bounelis P; Chatham JC; Marchase RB
    J Mol Cell Cardiol; 2006 Feb; 40(2):303-12. PubMed ID: 16337959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.